BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19275498)

  • 21. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries.
    ; Lodi S; del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Olson A; van Sighem A; Reiss P; Sabin C; Jose S; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Vourli G; Antoniadou A; Dabis F; Vandenhede MA; Costagliola D; Abgrall S; Hernán MA
    AIDS; 2014 Oct; 28(16):2461-73. PubMed ID: 25265230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.
    Hogg RS; Heath KV; Yip B; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    JAMA; 1998 Feb; 279(6):450-4. PubMed ID: 9466638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender and survival after AIDS in Rio de Janeiro, Brazil.
    Santoro-Lopes G; Harrison LH; Moulton LH; Lima LA; de Pinho AM; Hofer C; Schechter M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):403-7. PubMed ID: 9833750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 cell counts at the third month of HAART may predict clinical failure.
    d'Arminio Monforte A; Testori V; Adorni F; Castelnuovo B; Bini T; Testa L; Moscatelli G; Chiesa E; Rusconi S; Abeli C; Sollima S; Musicco M; Meroni L; Galli M; Moroni M
    AIDS; 1999 Sep; 13(13):1669-76. PubMed ID: 10509568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.
    McNaghten AD; Hanson DL; Jones JL; Dworkin MS; Ward JW
    AIDS; 1999 Sep; 13(13):1687-95. PubMed ID: 10509570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
    Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
    AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
    Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of initial AIDS-defining illness in survival following AIDS.
    Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
    AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Trend of HIV/AIDS Patients Starting Antiretroviral Therapy in South Korea between 2001 and 2015.
    Kim YC; Ahn JY; Kim HY; Song JY; Park DW; Kim MJ; Choi HJ; Kim SW; Kee MK; Han MG; Yoo M; Kim SM; Choi Y; Choi BY; Kim SI; Choi JY
    Yonsei Med J; 2020 Aug; 61(8):705-711. PubMed ID: 32734734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiological and clinical characteristics of HIV/AIDS patients followed-up in Cappadocia region: 18 years experience].
    Alp E; Bozkurt I; Doğanay M
    Mikrobiyol Bul; 2011 Jan; 45(1):125-36. PubMed ID: 21341167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.
    Baker JV; Peng G; Rapkin J; Abrams DI; Silverberg MJ; MacArthur RD; Cavert WP; Henry WK; Neaton JD;
    AIDS; 2008 Apr; 22(7):841-8. PubMed ID: 18427202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
    Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
    PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.
    Shiels MS; Cole SR; Wegner S; Armenian H; Chmiel JS; Ganesan A; Marconi VC; Martinez-Maza O; Martinson J; Weintrob A; Jacobson LP; Crum-Cianflone NF
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):485-90. PubMed ID: 18614916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
    Skiest DJ; Crosby C
    AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.